Clinical Trial: Bupropion for the Treatment of Methamphetamine Dependence - 1
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Bupropion for the Treatment of Methamphetamine Dependence
Brief Summary: The purpose of this study is to assess the efficacy and safety of bupropion in reducing methamphetamine use in subjects with methamphetamine dependence
Detailed Summary: A double-blind, placebo-controlled, parallel-group design study in which 100 subjects will be randomly assigned to placebo or bupropion for 12 weeks with follow-up assessments 4 weeks following treatment. Adaptive randomization will be used to balance treatment groups based on gender.
Sponsor: National Institute on Drug Abuse (NIDA)
Current Primary Outcome:
- Severity addiction
- Methamphetamine use
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: National Institute on Drug Abuse (NIDA)
Dates:
Date Received: September 18, 2003
Date Started: July 2003
Date Completion: June 2005
Last Updated: January 11, 2017
Last Verified: July 2008
